Internationalvaccineinstitute

02/22/2019

Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial

    SEOUL, Korea, JAKARTA, Indonesia, February 22, 2019 — Scientists from Bio Farma, the University of Indonesia, and the International Vaccine Institute (IVI), recently published the results of a phase I clinical trial study of a novel typhoid conjugate vaccine involving Indonesian adults and […]
03/02/2019

IVI BOT and SAG members at ‘Improving Global Health – A Symposium Honoring Dr. Adel Mahmoud’s Legacy’

  Several members of the IVI Board of Trustees and its Scientific Advisory Group pose for a photo at a diner held at the College of Physicians in Philadelphia on February 27, 2019 on the occasion of the ‘Improving Global Health – A Symposium Honoring […]
03/05/2019

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

  SEOUL, Korea — The International Vaccine Institute (IVI) has been awarded a $3,238,974 grant from the Bill & Melinda Gates Foundation to provide technical assistance support for studies to measure the effectiveness of typhoid conjugate vaccine (TCV) in West Africa. This grant comes after […]
03/26/2019

IVI Director General addresses BactiVac 2nd Annual Network Meeting

IVI Director General Dr. Jerome Kim gives his talk entitled ‘The Challenge of Bacterial Vaccines for Global Health’ at the BactiVac 2nd Annual Network Meeting. IVI Director General, Dr. Jerome Kim delivered a talk on The Challenge of Bacterial Vaccines for Global Health at the BactiVac 2nd […]